Who is sponsoring NCT01044277?

NCT01044277 is sponsored by Milton S. Hershey Medical Center.

What condition does NCT01044277 study?

NCT01044277 studies Healthy Adults.

What drugs are being tested in NCT01044277?

Interventions: Glutathione supplementation, Gluthathione peroxidases, Placebo.

What is the status of NCT01044277?

NCT01044277 is currently COMPLETED.

Last reviewed 2022-08-31 · How we verify

Effect of Oral Glutathione Supplementation on the Levels of Blood Glutathione and Markers of Oxidative Stress in Healthy Adults (Glutathione Supplementation and Health (GSH) Study)

NCT01044277 NA COMPLETED

This trial is designed to provide evidence of the efficacy of glutathione supplementation and health(GSH) and includes the assessment of both short term and long term effects. Based on previous laboratory animal studies and clinical data, the investigators anticipate that the effects of oral GSH supplementation will be progressive and cumulative. The study will also allow for the evaluation of effects of withdrawal of the supplement on the outcome variables.

Details

Lead sponsor	Milton S. Hershey Medical Center
Phase	NA
Status	COMPLETED
Enrolment	61
Start date	2010-02
Completion	2014-10

Conditions

Healthy Adults

Interventions

Glutathione supplementation
Gluthathione peroxidases
Placebo

Primary outcomes

Evaluation of the effect of glutathione on key biomarkers — 6 to 7 months
Blood glutathione status

Countries

United States